Indivior Pharmaceuticals, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. It develops...
10 insider purchases on record · latest filing 2026-08-27.
Insiders have also filed 3 sale transactions at INDV.